After beating estimates last quarter by $0.04, Itron
What analysts say
- Buy, sell, or hold?: Analysts are bullish on this stock with 15 analysts rating it as a buy and only two rating it as a sell. Analysts like Itron better than competitor Avista overall.
- Revenue forecasts: On average, analysts predict $570.8 million in revenue this quarter. That would represent a rise of 0.2% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $1.05 per share. Estimates range from $0.90 to $1.17.
What our community says
CAPS All-Stars are solidly backing the stock with 97.4% granting it an outperform rating. The community at large agrees with the All-Stars with 95.4% assigning it a rating of outperform. Fools are gung-ho about Itron and haven't been shy with their opinions lately, logging 152 posts in the past 30 days. Despite the majority sentiment in favor of Itron, the stock has a middling CAPS rating of three out of five stars.
Itron's income has fallen year over year by an average of more than twofold.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Itron now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.